Skip to main content
Jafron Biomedical Co.,Ltd. logo

Jafron Biomedical Co.,Ltd. — Investor Relations & Filings

Ticker · 300529 ISIN · CNE100002995 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,842 across all filing types
Latest filing 2022-06-28 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300529

About Jafron Biomedical Co.,Ltd.

https://www.jafron.com

Jafron Biomedical Co.,Ltd. specializes in the research, development, and manufacturing of biomaterials and equipment for blood purification. The company is a primary provider of hemoperfusion technology, focusing on the production of adsorbent cartridges designed to remove specific toxins and inflammatory mediators from the bloodstream. Its core product portfolio includes the HA series of hemoperfusion cartridges, which are applied in clinical settings for end-stage renal disease, acute poisoning, critical care, and liver failure. Beyond consumables, the company develops blood purification machines and integrated treatment systems. These solutions target clinical applications in nephrology, intensive care, and hepatology. By leveraging advanced resin adsorption technology, the company provides specialized extracorporeal blood treatment options aimed at improving patient outcomes in complex medical conditions.

Recent filings

Filing Released Lang Actions
防止控股股东及其关联方资金占用制度（2022年6月）
Governance Information Classification · 95% confidence The document is a detailed internal policy titled '防止控股股东及其关联方资金占用专项制度' (Special System to Prevent Funds Occupation by Controlling Shareholders and Their Related Parties) issued by 健帆生物科技集团股份有限公司. It outlines principles, responsibilities, and procedures to prevent misuse of company funds by controlling shareholders and related parties. The content is regulatory and governance-focused, detailing internal controls, responsibilities of directors and management, and legal compliance. It does not contain financial statements, earnings data, or audit results. It is not an announcement or a brief notice but a substantive governance document. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2022-06-28 Chinese
董事会审计委员会年报审议工作规则（2022年6月）
Governance Information Classification · 95% confidence The document is titled '审计委员会年报审议工作规则' which translates to 'Audit Committee Annual Report Review Working Rules'. It outlines the responsibilities and procedures of the audit committee in reviewing the company's annual report, including coordination with auditors, review of financial statements, and confidentiality obligations. The document is a set of internal rules or guidelines related to the audit committee's role in the annual report process, rather than the annual report itself or an audit report. It does not contain financial data or audit results but focuses on governance and procedural aspects. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is short (1105 characters), consistent with a governance guideline rather than a full report.
2022-06-28 Chinese
总经理工作细则（2022年6月）
Governance Information Classification · 95% confidence The document is titled '总经理工作细则' which translates to 'General Manager Work Rules' or 'General Manager Operating Procedures'. It details the qualifications, responsibilities, appointment procedures, powers, reporting duties, and performance evaluation of the company's general manager and other managerial personnel. It references company governance rules, laws, and regulations but does not contain financial statements, earnings data, or any form of financial results. It is a governance-related internal policy document outlining management roles and responsibilities rather than a report or announcement of financial or corporate events. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2022-06-28 Chinese
股东大会累积投票制实施细则（2022年6月）
Governance Information Classification · 95% confidence The document is titled as 'Implementation Rules for Cumulative Voting System at the Shareholders' Meeting' of a company. It details the procedures and rules for electing directors and supervisors using cumulative voting at the shareholders' meeting. It references company governance, shareholder voting rights, and election procedures. There is no financial data, no mention of financial results, no audit information, no legal proceedings, no capital changes, no voting results announcement, and no meeting presentation materials. The document is a governance-related procedural document about shareholder voting and board election rules, which fits the category of Governance Information (CGR). The document length is short and it is not an announcement of a report but a substantive governance rule document. Therefore, the best classification is Governance Information (CGR).
2022-06-28 Chinese
对外担保管理制度（2022年6月）
Governance Information Classification · 95% confidence The document is titled '对外担保管理制度' which translates to 'External Guarantee Management System' and is issued by 健帆生物科技集团股份有限公司. It is a detailed internal policy document outlining the rules, procedures, responsibilities, and disclosure requirements related to the company's external guarantees. It references relevant laws and regulations, approval authorities, risk control measures, and disclosure obligations. The document is not a financial report, earnings release, or announcement but rather a governance or management policy document. It does not contain financial statements or audit results, nor is it a regulatory announcement or voting result. Given the content focuses on internal rules and governance practices related to external guarantees, the most appropriate classification is Governance Information (CGR).
2022-06-28 Chinese
公司章程（2022年6月）
Governance Information Classification · 100% confidence The document is titled as the Articles of Association (章程) of 健帆生物科技集团股份有限公司 dated June 2022. It contains detailed provisions about the company's organization, shareholder rights, share issuance, share transfer, shareholder meetings, and governance structure. It references Chinese company law and securities law, and includes detailed rules on shareholder meetings, voting, and board responsibilities. This is a governance document outlining the company's internal rules and governance practices rather than a financial report, announcement, or other filing type. It is not an Annual Report, Interim Report, Earnings Release, or any other financial or regulatory filing. It is a governance information document describing the company's articles of association and governance framework. Therefore, the appropriate classification is Governance Information (CGR). The document length (15,000 characters) and content confirm it is the full governance document, not just an announcement or summary.
2022-06-28 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.